Showing results (231-240 of 319) with videos related to
Sort By:
Pageof 32
Cancer Research and Treatment|August 22, 2014
Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and ChildrenSun Min Lim, Cheol Joo Yoo, Jung Woo Han, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trialAnn-Lii Cheng, Yoon-Koo Kang, Deng-Yn Lin, et al.International Journal of Molecular Medicine|January 5, 2006
Systematic analysis of cDNA microarray-based CGHChan Hee Park, Ha Jin Jeong, Yeon Ho Choi, et al.Journal for Immunotherapy of Cancer|October 23, 2019
Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancerHyung Soon Park, Woo Sun Kwon, Sejung Park, et al.Oncotarget|October 6, 2017
Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancerJi Soo Park, Jong-Chan Youn, Chi Young Shim, et al.Cancer Medicine|October 25, 2021
Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancerTorben Steiniche, Sun Young Rha, Hyun Cheol Chung, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 23, 2013
Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumorsHan Sang Kim, Sang Joon Shin, Sang Cheol Kim, et al.Molecular Therapy Oncolytics|September 30, 2020
Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric CancerMinkyu Jung, Yanping Yang, Jaclyn E McCloskey, et al.Oncotarget|January 27, 2016
Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascitesByungho Lim, Chan Kim, Jeong-Hwan Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2022
Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II TrialKensei Yamaguchi, Yung-Jue Bang, Satoru Iwasa, et al.Pageof 32